Metronidazole Precursor: Chloromethyl Carbonochloridate Impurity Thresholds
Chloromethyl Carbonochloridate Purity Grades and HPLC Peak Purity Specifications for Metronidazole Precursor Synthesis
In the synthesis of metronidazole, a nitroimidazole antibiotic, the selection of a high-purity chloromethyl carbonochloridate (CAS 22128-62-7) is critical. This reagent, also known as chloromethyl chloroformate or chloromethoxycarbonyl chloride, serves as a key intermediate in introducing the chloromethyl carbamate protecting group. For procurement managers, understanding the relationship between industrial purity grades and downstream impurity profiles is essential. Our product, supplied by NINGBO INNO PHARMCHEM CO.,LTD., is positioned as a drop-in replacement for existing sources, offering identical technical parameters while optimizing cost-efficiency and supply chain reliability.
Typical commercial grades range from 97% to 99% purity, but for metronidazole precursor synthesis, HPLC peak purity is the decisive metric. A purity of ≥98.5% by GC is common, yet HPLC analysis at 210 nm often reveals trace impurities that can affect the final API. We have observed that batches with a single max impurity <0.5% and total impurities <1.0% consistently yield metronidazole intermediates with minimal byproduct formation. Please refer to the batch-specific COA for exact values. In our experience, a non-standard parameter to monitor is the presence of a late-eluting peak in HPLC, often corresponding to a dimeric chloroformate species, which can form during prolonged storage. This impurity, if above 0.2%, may lead to cross-linked byproducts in the subsequent alkylation step.
For those exploring alternative synthesis routes, the use of chloromethyl chlorocarbonate as a reagent demands rigorous quality assurance. We recommend requesting a COA that includes both GC and HPLC purity profiles, as GC alone may not detect non-volatile impurities. Our internal studies, detailed in our article on managing chloromethyl carbonochloridate exotherms in tenofovir coupling, highlight the importance of impurity profiling in exothermic reactions, a lesson directly applicable to metronidazole synthesis.
Comparative COA Breakdown: Acid Value Limits, Peroxide Contaminants, and Phenolic Byproduct Thresholds
A thorough COA comparison is vital when qualifying a new source of carbonochloridic acid chloromethyl ester. The table below summarizes typical specifications for industrial-grade material versus our high-purity grade tailored for API intermediates.
| Parameter | Industrial Grade | High-Purity Grade (INNO Pharmchem) |
|---|---|---|
| Assay (GC) | ≥97.0% | ≥99.0% |
| HPLC Purity (210 nm) | Not specified | ≥98.5% |
| Acid Value (mg KOH/g) | ≤5.0 | ≤2.0 |
| Peroxides (as H₂O₂) | ≤50 ppm | ≤10 ppm |
| Phenolic Byproducts (HPLC) | Not controlled | ≤0.1% |
| Appearance | Colorless to pale yellow liquid | Clear, colorless liquid |
Acid value is a critical, often overlooked parameter. Elevated acid levels, typically from hydrolysis to chloroformic acid chloromethyl ester, can catalyze side reactions during metronidazole precursor formation, leading to increased impurity G (a known metronidazole related substance). We have found that maintaining acid value ≤2.0 mg KOH/g significantly reduces the formation of this impurity. Peroxide contaminants, arising from exposure to air, pose a safety risk and can oxidize sensitive intermediates. Our specification of ≤10 ppm is achieved through inert atmosphere packaging. Phenolic byproducts, though not commonly listed, can originate from stabilizers in certain manufacturing processes. Our high-purity grade minimizes these to ≤0.1%, ensuring a cleaner reaction profile. For a deeper dive into reaction optimization, our Spanish-language resource on acoplamiento de tenofovir y manejo de exotermias provides cross-reaction insights.
Solvent Incompatibility Warnings and Crystallization Yield Optimization in API Intermediate Production
Selecting the correct solvent system for reactions involving chloromethyl carbonochloridate is paramount. This reagent is highly reactive with nucleophilic solvents. Alcohols, amines, and even water cause rapid decomposition, generating HCl and CO₂. For metronidazole precursor synthesis, typical solvents include dichloromethane, tetrahydrofuran, or acetonitrile, used under strictly anhydrous conditions. A common question is: "What is the best solvent for metronidazole?" While metronidazole itself is slightly soluble in water and more soluble in ethanol, the precursor synthesis step using chloromethyl carbonochloridate must be performed in aprotic solvents to avoid reagent degradation.
We have encountered a non-standard parameter during scale-up: the impact of trace moisture on crystallization yield. Even with solvents dried over molecular sieves, ambient humidity during addition can introduce enough water to generate acidic byproducts. These byproducts can inhibit crystallization of the metronidazole intermediate, reducing yield by up to 10%. To mitigate this, we recommend using freshly distilled solvents and maintaining a nitrogen atmosphere. Additionally, the exothermic nature of the reaction requires controlled addition; our article on managing exotherms provides practical guidance. For procurement managers, ensuring the supplier provides material in moisture-resistant packaging is as crucial as the COA specifications.
Bulk Packaging, Storage Stability, and Non-Standard Parameter Handling for Industrial Supply Chains
For industrial supply chains, packaging and storage conditions directly influence the quality of chloromethyl carbonochloridate upon receipt. Our standard bulk packaging includes 210L steel drums with PTFE-lined closures, ensuring compatibility and preventing moisture ingress. For larger volumes, IBC totes can be arranged. The reagent is classified as a hazardous chemical (corrosive, toxic), and proper labeling and documentation are provided.
Storage stability is a key concern. When stored at 2–8°C under nitrogen, the product maintains its specifications for 12 months. However, a non-standard parameter we monitor is the viscosity shift at sub-zero temperatures. At -5°C, the liquid becomes noticeably more viscous, which can complicate pumping and metering in automated synthesis setups. We advise customers to warm the drums to 15–20°C before use and to avoid repeated freeze-thaw cycles, as these can accelerate dimer formation. Another edge-case behavior is the potential for trace iron contamination from drum linings, which can catalyze decomposition. Our drums are epoxy-lined to prevent this. For custom synthesis or quality assurance inquiries, our technical team can provide guidance on handling these parameters.
Frequently Asked Questions
What are acceptable acid value thresholds for chloromethyl carbonochloridate in metronidazole synthesis?
Based on our field experience, an acid value ≤2.0 mg KOH/g is recommended to minimize side reactions and impurity G formation. Higher acid values can lead to inconsistent yields and require additional purification steps.
How do HPLC and GC detection limits compare for chloroformate degradation products?
GC is suitable for volatile impurities but may miss non-volatile degradation products like dimeric species. HPLC with UV detection at 210 nm provides a more comprehensive profile, with detection limits typically around 0.05% for individual impurities. We recommend using both methods for a complete assessment.
What batch-to-batch consistency metrics should I expect?
Our high-purity grade consistently delivers assay ≥99.0% by GC, HPLC purity ≥98.5%, and acid value ≤2.0. We provide a batch-specific COA with every shipment, and our statistical process control data shows a relative standard deviation of less than 1% for key parameters over the last 20 batches.
What is the CAS number of metronidazole impurity G?
Metronidazole impurity G is known as 2-methyl-5-nitroimidazole-1-acetic acid, with CAS number 110578-73-9. Controlling chloromethyl carbonochloridate quality helps limit this impurity.
Is metronidazole compatible with D5W?
Yes, metronidazole is compatible with D5W (5% dextrose in water) for intravenous administration. However, this compatibility refers to the final drug product, not the precursor synthesis step.
What is the difference between metronidazole and metronidazole benzoate?
Metronidazole benzoate is an ester prodrug of metronidazole, often used in oral suspensions to mask the bitter taste. The synthesis of metronidazole benzoate may also involve chloroformate chemistry, but the impurity thresholds differ.
Sourcing and Technical Support
As a global manufacturer of high-purity chloromethyl carbonochloridate, NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting your metronidazole precursor synthesis with consistent quality and reliable supply. Our product serves as a seamless drop-in replacement, backed by comprehensive COA documentation and technical expertise. Whether you need custom synthesis support or bulk pricing, our team is ready to assist. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.